Infectious Diseases Society of America Guidelines on Infection Prevention for Healthcare Personnel Caring for Patients With Suspected or Known COVID-19 …
JB Lynch, P Davitkov, DJ Anderson… - Clinical Infectious …, 2024 - academic.oup.com
Background Since its emergence in late 2019, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) continues to pose a risk to healthcare personnel (HCP) and …
coronavirus 2 (SARS-CoV-2) continues to pose a risk to healthcare personnel (HCP) and …
Tracheostomy for COVID-19: evolving best practice
T Williams, BA McGrath - Annual Update in Intensive Care and …, 2021 - Springer
Tracheostomy is an established tool for the management of the critically ill. The dominant
indication is to facilitate weaning from invasive respiratory support, and it is no surprise that …
indication is to facilitate weaning from invasive respiratory support, and it is no surprise that …
[HTML][HTML] Factors associated with a prolonged negative conversion of viral RNA in patients with COVID-19
C Bennasrallah, I Zemni, W Dhouib, H Sriha… - International journal of …, 2021 - Elsevier
Objectives The aim of this study was to identify the factors influencing the delay in severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA negative conversion …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA negative conversion …
[HTML][HTML] Molecular detection of SARS-COV-2 in exhaled breath at the point-of-need
T Stakenborg, J Raymenants, A Taher… - Biosensors and …, 2022 - Elsevier
The SARS-CoV-2 pandemic has highlighted the need for improved technologies to help
control the spread of contagious pathogens. While rapid point-of-need testing plays a key …
control the spread of contagious pathogens. While rapid point-of-need testing plays a key …
A randomized clinical trial of regdanvimab in high-risk patients with mild-to-moderate coronavirus disease 2019
JY Kim, O Săndulescu, LL Preotescu… - Open forum …, 2022 - academic.oup.com
Background We evaluated clinical effectiveness of regdanvimab (CT-P59), a severe acute
respiratory syndrome coronavirus 2 neutralizing monoclonal antibody, in reducing disease …
respiratory syndrome coronavirus 2 neutralizing monoclonal antibody, in reducing disease …
[HTML][HTML] Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February …
M Vicentini, F Venturelli, P Mancuso… - …, 2023 - eurosurveillance.org
Background Understanding the epidemiology of reinfections is crucial for SARS-CoV-2
control over a long period. Aim To evaluate the risk of SARS-CoV-2 reinfection by …
control over a long period. Aim To evaluate the risk of SARS-CoV-2 reinfection by …
Efficacy of a polyphenolic, standardized green tea extract for the treatment of COVID-19 syndrome: A proof-of-principle study
S Bettuzzi, L Gabba, S Cataldo - Covid, 2021 - mdpi.com
The lack of therapies for moderate COVID-19 syndrome prompted us to use a standardized
polyphenolic green tea extract rich in catechins during the lockdown due to the pandemic in …
polyphenolic green tea extract rich in catechins during the lockdown due to the pandemic in …
COVID-19 challenges: From SARS-CoV-2 infection to effective point-of-care diagnosis by electrochemical biosensing platforms
D Campos-Ferreira, V Visani, C Córdula… - Biochemical …, 2021 - Elsevier
Abstract In January 2020, the World Health Organization (WHO) identified a new zoonotic
virus, SARS-CoV-2, responsible for causing the COVID-19 (coronavirus disease 2019) …
virus, SARS-CoV-2, responsible for causing the COVID-19 (coronavirus disease 2019) …
Duration of SARS-CoV-2 RNA positivity from various specimens and clinical characteristics in patients with COVID-19: a systematic review and meta-analysis
Y Okita, T Morita, A Kumanogoh - Inflammation and regeneration, 2022 - Springer
Background The duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) RNA positivity will be important to prevent the spread of coronavirus disease 2019 …
2) RNA positivity will be important to prevent the spread of coronavirus disease 2019 …
Prolonged viral shedding and antibody persistence in patients with COVID-19
SARS-CoV-2 as a new global threat has affected global population for one year. Despite the
great effort to eradicate this infection, there are still some challenges including different viral …
great effort to eradicate this infection, there are still some challenges including different viral …